Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.
Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
To optimise the catalyst performance and highlight the advantages of a catalyst to create green fuel for the aviation sector through carbon capture.
Incorporated in August 2021
Origin: Oxford University, Department of Chemistry
OxCept is a team of security and communication experts creating military-grade authentication security products for business teams.
Incorporated in January 2014
Origin: Oxford University, Department of Computer Science
OxCo produces videos in collaboration with researchers, teaches academics how to leverage video technologies, and convenes unique hybrid events.
Incorporated in August 2022
Origin: Oxford University, Department of Sociology
Oxford Digital Innovation encompasses three different products. Two of them are online health records platform which aim to integrate NHS data (Zygote – IVF platform – and Simba – maternity platform). The 3rd platform is a virtual hospital which is aimed at scheduling appointments for patients and enable online consultations in specific specialisations, starting with eye care, skin care, pathology and dental medicine.
Incorporated in August 2020
Origin: Oxford University, Nuffield Dept of Women's and Reproductive Health
To develop and commercialise a rapid non-lab based diagnostic test for viral infections, with the first focus on Covid19.
Incorporated in December 2021
Origin: Oxford University, Department of Physics
Development of a platform for the standardisation of assetments to facility language, reading and arithmetic skills in children.
Incorporated in April 2020
Origin: Oxford University, Department of Education
Revolutionary healthcare technology that measures medical vital signs without physical contact.
Incorporated in August 2012
Origin: Oxford University, Institute of Biomedical Engineering
Oxford Electromagnetic Solutions - smart asset management through underground network visibility.
Incorporated in June 2010
Origin: Oxford University, Department of Engineering Science
Oxidative Enzymes for the Pulp and Paper Industry.
Incorporated in February 2010
Origin: Oxford University, Department of Chemistry
Oxford Advanced Surfaces develops and commercialises advanced materials and technology solutions leveraging breakthrough surface modification technology.
Incorporated in September 2006
Origin: Oxford University, Department of Chemistry
Genetic Genealogy
Incorporated in April 2001
Origin: Oxford University
Specialised archaeological-based IT applications.
Incorporated in June 2001
Origin: Oxford University, School of Archaeology
Drug Development. Oxford Asymmetry merges with Evotec BioSystems April 2009.
Incorporated in April 1992
Origin: Oxford University, Department of Chemistry
Pollination.
Incorporated in March 2001
Origin: Oxford University
Oxford BioDynamics offers a novel and revolutionary biomarker discovery platform technology in the diagnostics field of aberrant gene expression.
Incorporated in June 2007
Origin: Oxford University, Department of Pathology
Biomimetic spinning of fibres.
Incorporated in March 2002
Origin: Oxford University
Water quality monitoring devices based on electrochemical (bio)sensors.
Incorporated in August 2000
Origin: Oxford University, Department of Chemistry
Develops and commercialises enzymatic process technologies that yield high-value chemical compounds.
Incorporated in September 2013
Origin: Oxford University, Department of Chemistry
Software and patented approach to differential diagnosis of cognitive diseases
Incorporated in April 2019
Origin: Oxford University, Nuffield Department of Clinical Neurosciences
Pioneering biomarker technologies for cancer therapies.
Incorporated in December 2011
Origin: Oxford University, Radcliffe Department of Oncology
